Asset Details
Do you wish to reserve the book?
Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
Do you wish to request the book?
Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
2025
Overview
Helicobacter pylori ( H. pylori ) is a Group 1 gastric carcinogen increasingly implicated in extragastric digestive malignancies. This review synthesizes evidence on its role in liver, biliary, esophageal, colorectal, and pancreatic cancers. Based on its unique spiral morphology, flagellar motility bundle, and urease activity-mediated acidic niche adaptation, H. pylori disrupts host cellular homeostasis through multifactorial virulence mechanisms involving CagA/VacA synergy, and exploits antigenic variation and immunomodulatory strategies to achieve persistent gastric mucosal colonization and chronic infection. Emerging evidence suggests associations between H. pylori infection and nongastric digestive cancers, though relationships vary by site. For hepatocellular carcinoma (HCC), epidemiological studies indicate increased risk (OR 4.75), particularly with HCV coinfection, but mechanistic and cohort data remain conflicting. Biliary tract cancer (BTC) shows stronger epidemiological links, especially for cholangiocarcinoma (OR 4.18), supported by virulence factor detection. In esophageal cancer, H. pylori particularly CagA+ strains demonstrates a protective effect against adenocarcinoma but no significant association with squamous cell carcinoma. Colorectal cancer exhibits complex associations, with meta-analyses suggesting increased risk in East Asian populations and potential benefits from eradication therapy. Pancreatic cancer links remain inconsistent. Proposed mechanisms of H. pylori in extragastric cancers include chronic inflammation, virulence factor activity and microbiome disruption. This comprehensive review synthesizes contemporary evidence on the bacterium’s role in non-gastric digestive malignancies, examines pathways underlying its oncogenicity, and outlines translational implications for risk stratification and therapeutic innovation.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Ammonia
/ Antigens
/ Antigens, Bacterial - genetics
/ Bacterial Proteins - genetics
/ Bacterial Proteins - metabolism
/ Digestive System Neoplasms - epidemiology
/ Digestive System Neoplasms - microbiology
/ Flagella
/ Helicobacter Infections - complications
/ Helicobacter Infections - microbiology
/ Helicobacter pylori - genetics
/ Helicobacter pylori - pathogenicity
/ Helicobacter pylori - physiology
/ Humans
/ Proteins
/ Urease
We currently cannot retrieve any items related to this title. Kindly check back at a later time.